Spotting undervalued shares, Savills & weight-loss drugs: The Companies and Markets Show @InvestorsChronicle
Spotting undervalued shares, Savills & weight-loss drugs: The Companies and Markets Show  @InvestorsChronicle
Uploaded August 2025 | Updated September 2026, 2 weeks ago
We begin with Hugh Moorhead and recent results from Savills (SVS), which were in line with expectations. Hugh and Dan unpack what divisions brought in the highest profits, a breakdown of a handful of global performances, and what the business’s valuation appears to be.

Next up James Norrington joins to unpack our latest Big Read on sum-of-the-parts valuations. James explains the thinking behind the piece, how it can help find stocks trading at less than their worth, and how to tell if a company is focusing on the right part of a business.

Lastly, Julian Hofmann covers Novo Nordisk (DK:NOVO.B), which saw shares rise after Eli Lilly’s (US:LLY) oral weight-loss pill underwhelmed regulators. Competition is still fierce in the sector, but a new Novo CEO could give the company the boost it needs. #Investing #finance #personalfinance #investments #business

Listen to our podcasts: investorschronicle.co.uk/podcasts
Subscribe to Investors' Chronicle: investorschronicle.co.uk/product-matrix

Investors' Chronicle has supported private investors in the UK for over 160 years by highlighting rewarding investment opportunities. Our award-winning expert writers research hundreds of companies and funds suitable for all risk appetites, to provide clear, independent recommendations for individual investors who want to make their money grow and outline how to make the most of different types of investment vehicles at all stages of your life.

Follow The Companies and Markets Show on @YouTube: youtube.com/playlist?list=PLnrcXTQl38frCLdb4HDxepjhvod-gN662

Follow Lee and the IC: youtube.com/playlist?list=PLnrcXTQl38fqB-A5bJJ-GtFjm3Q9S9Xnx

Listen to our interviews here: youtube.com/playlist?list=PLnrcXTQl38fo1Oio19rTsLt9fD2s4hKst

Follow us on LinkedIn: linkedin.com/showcase/financial-times---investors-chronicle

Follow us on Instagram: instagram.com/investorschronicle/?hl=en

Get the latest investing updates on WhatsApp: whatsapp.com/channel/0029VaD6zjW9WtBxc0gFG13F
Spotting undervalued shares, Savills & weight-loss drugs: The Companies and Markets ShowIsas, apps and platforms: Where to invest your moneyGSK acquires lung cancer specialist in $10.6bn dealCelebration of Investment Awards 2025 HighlightsCan PHPs dividend keep growing?What lies ahead for Ceres Power?How the Budget impacts your financesWhy UK pub stocks are rallyingWhat has caused AstraZeneca shares to jump?Is Africa the next big opportunity for your investing?Why Auction Tech rejected 11 takeover offers despite a year of losses and investor pressureThe US is not the only game in town: Maggie Fanari of RIT Capital
Investors Chronicle |

Spotting undervalued shares, Savills & weight-loss drugs: The Companies and Markets Show

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER